Regenerative Medicine For Cartilage Market 2022 – By Treatment Modality ( Cell-Based, Non-Cell-Based), By Treatment Type ( Palliative, Intrinsic Repair Stimulus, Others Skin Resurfacing ), By Site (Knee Cartilage Repair, Ribs), By Application (Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration), By End-User: Ambulatory Surgical Centers, Hospitals & Clinics), And By Region, Opportunities And Strategies – Global Forecast To 2031

Starting Price : $5000.00 | Pages : 276 | Published : June 2022 | SKU CODE : o&s438 | | Format :

Request Sample

Regenerative Medicine For Cartilage Market

The regenerative medicine for cartilage market consists of sales of regenerative medicines for the cartilage by entities (organizations, sole traders, and partnerships) that have the capacity to grow tissues and organs in the lab and safely implant them when the body cannot regenerate itself, as observed for cartilage tissue after injury or wear. Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives.

Cartilage is essentially a white shiny material that helps cushion and cover the area where the bones meet the joints. It serves as a lubricating surface as well as a shock absorber. Cartilage damage can be seen as a hole or crater on the otherwise smooth surface of the joint. If left untreated, the joint can become stiff, swollen and painful. It may even progress to a stage that requires a total joint replacement with metal and plastic components.

Regenerative Medicine For Cartilage Market Size

The global regenerative medicine for cartilage market reached a value of nearly $3,779.4 million in 2021, having increased at a compound annual growth rate (CAGR) of 4.6% since 2016. The global regenerative medicine for cartilage market size is expected to grow from $3,779.4 million in 2021 to $5,017.3 million in 2026 at a rate of 5.8%. The global regenerative medicine for cartilage market size is then expected to grow at a CAGR of 6.0% from 2026 and reach $6,727.0 million in 2031.  

Growth in the historic period in the regenerative medicine for cartilage market resulted from a rise in awareness and expenditure in healthcare, changes in lifestyles, ability to command high prices, strong economic growth in emerging markets, increase in insurance coverage, and rapid growth in elderly population. The market was restrained by stringent regulations from regulators, inadequate reimbursements, and low healthcare access.

Going forward, increasing prevalence of chronic diseases, rising geriatric population, technological advances, and a rise in healthcare expenditure are expected to be the major drivers of the market. Factors that could hinder the growth of the market in the future include rising popularity of alternative therapies and natural remedies, tissue-engineered products and biomaterials lagging in adoption, and low per capita healthcare expenditure.

Regenerative Medicine For Cartilage Market Drivers

The key drivers of the regenerative medicine for cartilage market include:

Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases, such as arthritis across the globe, is likely to contribute to the growth of the stem cell therapy, and hence the regenerative medicine for cartilage market during the forecast period. For instance, it has been calculated that, in 2001, chronic diseases contributed approximately 60% of the 56.5 million total reported deaths in the world and approximately 46% of the global burden of disease.  The proportion of the burden of NCDs is expected to increase to 57% by 2020. According to the Global Burden of Disease Study 2019 (GBD 2019) results, Osteoarthritis affects 7% of the global population, more than 500 million people worldwide, with women disproportionately affected by the condition.  Socio-economic risk factors and the elderly population are a major cause for increasing chronic diseases, thereby driving the growth of the regenerative medicine for cartilage market.

Regenerative Medicine For Cartilage Market Restraints

The key restraints on the regenerative medicine for cartilage market include:

Rising Popularity of Alternative Therapies and Natural Remedies

Alternative treatment methods and natural remedies are increasingly becoming popular globally and this is expected to have a negative impact on the revenues of pharmaceutical drug companies. Treatments in the fields of homeopathy, Ayurveda, yoga, acupuncture, sujok therapy are gaining popularity and slowly replacing some traditional hospital practices. For instance, OA is a challenging disease for doctors due to the limitation of the joint cartilage’s capacity to repair itself. Though new treatment approaches, in particular with mesenchymal stem cells (MSCs) that integrate the tissue engineering (TE) of cartilage tissue, are promising, they are not only expensive but more often do not lead to the regeneration of joint cartilage. Therefore, there is an increasing need for novel, safe, and more effective alternatives to promote cartilage joint regeneration and TE. Indeed, naturally occurring phytochemical compounds (herbal remedies) have a great anti-inflammatory, anti-oxidant, and anabolic potential, and they have received much attention for the development of new therapeutic strategies for the treatment of inflammatory diseases, including the prevention of age-related OA and cartilage TE.  Also, the global homeopathic product market was valued at $5.6 billion in 2018 and is projected to reach $18.6 billion by the end of 2027, growing at a CAGR of 14% during the forecast period. This is expected to continue during the forecast period and limit the demand for regenerative medicine for cartilage.

Regenerative Medicine For Cartilage Market Trends

Major trends influencing the regenerative medicine for cartilage market include:

Rising Strategic Collaborations, Partnerships And Agreements

Many companies in the regenerative medicine for cartilage market are strategically partnering and collaborating with other companies to broaden their product portfolios and expand their regenerative medicine for cartilage business. These collaborations are helping regenerative medicine manufacturing companies to enhance their ability to compete in specific therapy areas. For instance, In June 2019, FUJIFILM Corporation, a Japanese conglomerate operating in the realms of photography, optics, office and medical electronics, biotechnology, and chemicals, has invested JPY300 million ($2.67 million) in PuREC Co., Ltd. Fujifilm has also signed a business partnership agreement with PuREC concerning contract development and manufacturing of regenerative medicine products. PuREC is a company involved in conducting R&D for therapeutic REC (Rapidly Expanding Cell) preparations and marketing REC as research reagent.

Growing Use of Mesenchymal Stem Cell Technology in Cartilage Repair

Stem cell therapies are gradually being adopted as a treatment for bone-joint injuries including cartilage. Stem cells, specifically mesenchymal stem cells, are precursors of connective tissue and have distinctive characteristics of self-regeneration and differentiation into multiple lineages, including adipocytes, osteoblasts, and chondrocytes.  Early clinical trials are being performed to investigate the safety and effectiveness of human mesenchymal stem cells in the treatment of a broad range of conditions including cartilage repair. For example, currently, there are multiple clinical trials (CT) using hMSCs (Human Mesenchymal Stem Cells) for therapeutic purposes in a large number of clinical settings. The search strategy on clinicaltrials.gov has focused on the key term “Mesenchymal Stem Cells”, and the inclusion and exclusion criteria were separated into two stages. Stage 1, clinical trials on phases 1–4: location, the field of application, phase, and status. By July 2020, there were a total of 1,138 registered clinical trials. Most studies belong to either phase 2 (61.0%) or phase 1 (30.8%); most of them focused in the fields of traumatology, neurology, cardiology, and immunology.

Opportunities And Recommendations In The Regenerative Medicine For Cartilage Market

Opportunities –The top opportunities in the regenerative medicine for cartilage market segmented by treatment modality will arise in cell-based segment, which will gain $994.1 million of global annual sales by 2026. The top opportunities in the regenerative medicine for cartilage market segmented by treatment type will arise in palliative segment, which will gain $577.9 million of global annual sales by 2026. The top opportunities in the regenerative medicine for cartilage market segmented by site will arise in knee cartilage repair segment, which will gain $526.5 million of global annual sales by 2026. The top opportunities in the regenerative medicine for cartilage market segmented by application will arise in hyaline cartilage repair and regeneration segment, which will gain $807.6 million of global annual sales by 2026. The top opportunities in the regenerative medicine for cartilage market segmented by end use will arise in hospitals & clinics segment, which will gain $868.8 million of global annual sales by 2026. The regenerative medicine for cartilage market size will gain the most in the USA at $236.7 million.

Recommendations –To take advantage of the opportunities, The Business Research Company recommends the regenerative medicine for cartilage companies to focus on growing use of mesenchymal stem cell technology in cartilage repair, focus on investing in technology transfer and clinical translation, invest in biomaterial research to develop novel advanced injectable hydrogels techniques, focus on growing research on bioactive signals, expand in countries that offer incentives, include bundled payments options, offer competitively priced products, participate in trade shows and events, build strategic relationships with large-scale end-users and target hospitals including pharmacies to spread awareness on stem cell therapy.

Regenerative Medicine For Cartilage Market Segmentation

The regenerative medicine for cartilage market is segmented by treatment modality, by treatment type, by site by application, by end-use.
By Treatment Modality -
The regenerative medicine for cartilage market is segmented by treatment modality:
    • a) Cell-based
    • b) Non-cell-based
The cell-based segment was the largest segment of the regenerative medicine for cartilage market segmented by treatment modality, accounting for 91.2% of the total in 2021. Going forward, the non-cell-based segment is expected to be the fastest growing segment in the regenerative medicine for cartilage market segmented by treatment modality, at a CAGR of 11.6% during 2021-2026.
By Treatment Type -
The regenerative medicine for cartilage market is segmented by treatment type:
    • a) Palliative
    • b) Intrinsic repair stimulus
    • c) Others skin resurfacing
The palliative segment was the largest segment of the regenerative medicine for cartilage market segmented by treatment type, accounting for 38.3% of the total in 2021. Going forward, the palliative segment is expected to be the fastest growing segment in the regenerative medicine for cartilage market segmented by treatment type, at a CAGR of 7.0% during 2021-2026.
By Site -
The regenerative medicine for cartilage market is segmented by site:
    • a) Knee cartilage repair
    • b) Ribs
    • c) Others
The knee cartilage repair segment was the largest segment of the regenerative medicine for cartilage market segmented by site, accounting for 47.6% of the total in 2021. Going forward, the ribs segment is expected to be the fastest growing segment in the regenerative medicine for cartilage market segmented by site, at a CAGR of 6.4% during 2021-2026.
By End-Use -
The regenerative medicine for cartilage market is segmented by end-use:
    • a) Ambulatory surgical centers
    • b) Hospitals & clinics
    • c) Others
The hospitals & clinics segment was the largest segment of the regenerative medicine for cartilage market segmented by end use, accounting for 66.8% of the total in 2021. Going forward, hospitals & clinics segment is expected to be the fastest growing segment in the regenerative medicine for cartilage market segmented by end use, at a CAGR of 6.1% during 2021-2026.
By Application -
The regenerative medicine for cartilage market is segmented by application:
    • a) Hyaline cartilage repair and regeneration
    • b) Elastic cartilage repair and regeneration
    • c) Fibrous cartilage repair and regeneration
The hyaline cartilage repair and regeneration segment was the largest segment of the regenerative medicine for cartilage market segmented by application, accounting for 62.5% of the total in 2021. Going forward, the hyaline cartilage repair and regeneration segment
By Geography- The regenerative medicine for cartilage market is segmented by geography into
    • o Asia Pacific
      • •  China
      • •  Japan
      • •  India
      • •  Australia
      • •  Indonesia
      • •  South Korea
    • o North America
      • • USA
      o South America
      • • Brazil 
      o Western Europe
      • • UK 
      • • Germany 
      • • France 
      o Eastern Europe
      • • Russia 
      o Middle East
      o Africa
North America was the largest region in the regenerative medicine for cartilage market, accounting for 52.4% of the total in 2021. It was followed by the Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the regenerative medicine for cartilage market will be Middle East and Africa where growth will be at CAGRs of 31.9% and 30.7% respectively during 2021-2026. These will be followed by Eastern Europe and Asia Pacific, where the markets are expected to register CAGRs of 23.8% and 22.1% respectively during 2021-2026.

Regenerative Medicine For Cartilage Market Competitive Landscape

Major Competitors are:

  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.
  • B. Braun Melsungen AG
  • Arthrex Inc.
  • Other Competitors Include:

  • Vericel Corporation
  • Johnson & Johnson (DePuy Synthes)
  • MEDIPOST Co., Ltd.
  • CONMED Corporation
  • Orthocell Ltd.
  • China Biologic Products Holdings Inc.
  • China Regenerative Medicine International
  • AstraZeneca
  • ABLbio
  • Adimmune
  • Henlius
  • Innovent Biologics
  • Bio-Thera
  • Hisun Pharma
  • 3SBio
  • Beijing ShuangLu Pharmaceuticals
  • Qilu Pharmaceutical
  • Shanghai Fosun Pharmaceuticals
  • Biocon
  • Dr. Reddy’s
  • Mylan
  • Kyowa Hakko Kirin
  • Takeda
  • Mitsubishi Tanabe
  • AGC Biologics
  • Cellgenix Gmbh
  • BioTissue Technologies
  • Corin Group
  • Medical Import Ltd.
  • United Orthopedic Corporation UK Ltd
  • Lucideon (fka Ceram)
  • Orthonika
  • Merete
  • 3di GmbH
  • Aditus Medical GmbH
  • Anton Hipp GmbH
  • AREX SAS
  • Bäramed Instrumente GmbH
  • Biovision GmbH
  • Boneartis AG
  • GO German Orthopedic Implants GmbH
  • Innovations Medical GmbH
  • M.C. Medizintechnik-Export GmbH & Co. KG
  • MBP Medical Biomaterial Products GmbH
  • Vertex Pharmaceuticals Incorporated
  • Acelity L.P. Inc.
  • Celgene Corporation
  • StemCells, Inc
  • Organogenesis Inc
  • NuVasive, Inc
  • Japan Tissue Engineering Co., Ltd
  • Cytori Therapeutics Inc
  • Advantagene, Inc.
  • Mesoblast Ltd
  • Globus Medical
  • Osiris Therapeutics Inc.
  • Cryolife Inc
  • Integra Lifesciences Corporation
  • Medtronic Plc
  • Anika Therapeutics, Inc.
  • Organogenesis Inc
  • Rti Surgical
  • Geistlich Pharma AG
  • CartiHeal, Inc.
  • NuVasive Inc
  • DJO Global Inc.
  • Wright Medical Group
  • Joint Solutions Alliance Corporation (Canada)
  • Auxein (Maxico)
  • Aesculap, Inc (Canada)
  • AMEGA Biotech
  • BioMarin Pharmaceutical
  • Ache Laboratorios Farmaceuticos
  • Laboratorio Teuto
  • Myralis Industria Farmaceuticaa
  • LizarBio Therapeutics
  • Eurofarma Laboratorios
  • Laboratorios Saval
  • Biosonda Biotechnology
  • Laboratorios Legrand
  • Ipsum Clinical
  • Steris Applied Sterilization Technologies
  • Grupo Biotoscana
  • Julphar
  • Abbott Laboratories
  • Novartis
  • Pfizer
  • MSD
  • Novo Nordisk
  • Bayer
  • BBI Solutions
  • Aspen Pharmacare
  • Amoun Pharmaceuticals CO Ltd
  • 54gene
  • Baxter International
  • Altis Biologics
  • Cipla Medpro South Africa
  • Sanofi Genzyme
    1. Table Of Contents

      1. Regenerative Medicine For Cartilage Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Treatment Modality

      6.3. Segmentation By Treatment Type

      6.4. Segmentation By Site

      6.5. Segmentation By Application

      6.6. Segmentation By End-Use

      7. Regenerative Medicine For Cartilage Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Treatment Modality

      7.2.1. Cell-Based

      7.2.2. Non-Cell-Based

      7.3. Segmentation By Treatment Type

      7.3.1. Palliative

      7.3.2. Intrinsic Repair Stimulus

      7.3.3. Others

      7.4. Segmentation By Site

      7.4.1. Knee Cartilage Repair

      7.4.2. Ribs

      7.4.3. Others

      7.5. Segmentation By End-Use

      7.5.1. Ambulatory Surgical Centers

      7.5.2. Hospitals & Clinics

      7.5.3. Others

      7.6. Segmentation By Application

      7.6.1. Hyaline Cartilage Repair and Regeneration

      7.6.2. Elastic Cartilage Repair and Regeneration

      7.6.3. Fibrous Cartilage Repair and Regeneration

      7.6.4. Other Application

      8. Regenerative Medicine For Cartilage Market Trends And Strategies

      8.1. Rising Strategic Collaborations, Partnerships And Agreements

      8.2. Growing Use of Mesenchymal Stem Cell Technology in Cartilage Repair

      8.3. Increasing Research & Development On Use Of Novel Gene Therapy Technique in Cartilage Repair

      8.4. Rising Adoption Of Injectable Hydrogel Role In Cartilage Repair

      8.5. Growing Research On Bioactive Signals That Enhance Cartilage Repair

      8.6. Advancements In Technology Transfer And Clinical Translation

      8.7. Global Research Initiatives And Funding

      9. Impact Of COVID-19 On Regenerative Medicine For Cartilage

      9.1. Impact On Companies Manufacturing And Commercial Operations

      9.2. Future Outlook

      10. Global Regenerative Medicine For Cartilage Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      10.2.1. Drivers Of The Market 2016 – 2021

      10.2.2. Restraints On The Market 2016 – 2021

      10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      10.3.1. Drivers Of The Market 2021 – 2026

      10.3.2. Restraints On The Market 2021 – 2026

      11. Global Regenerative Medicine For Cartilage Market Segmentation

      11.1. Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Modality, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.2. Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.3. Global Regenerative Medicine For Cartilage Market, Segmentation By Site, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.4. Global Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.5. Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Regenerative Medicine For Cartilage Market, Regional And Country Analysis

      12.1. Global Regenerative Medicine For Cartilage Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.2. Global Regenerative Medicine For Cartilage Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Asia-Pacific Regenerative Medicine For Cartilage Market

      13.1. Asia-Pacific Regenerative Medicine For Cartilage Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.3. Asia-Pacific Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.4. Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.5. Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. Asia-Pacific Regenerative Medicine For Cartilage Market: Country Analysis

      13.7. China Regenerative Medicine For Cartilage Market

      13.8. China Regenerative Medicine For Cartilage Market Overview

      13.8.1. Market Information

      13.8.2. Background Information

      13.8.3. Government Initiatives

      13.8.4. Regulations

      13.8.5. Regulatory Bodies

      13.8.6. Major Associations

      13.8.7. Taxes Levied

      13.8.8. Corporate Tax Structure

      13.8.9. Investments

      13.8.10. Major Companies

      13.9. China Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.10. China Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.11. China Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.12. China Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.13. India Regenerative Medicine For Cartilage Market

      13.14. India Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.15. India Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.16. India Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.17. India Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.18. Japan Regenerative Medicine For Cartilage Market

      13.19. Japan Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.20. Japan Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.21. Japan Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.22. Japan Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.23. Australia Regenerative Medicine For Cartilage Market

      13.24. Australia Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.25. Australia Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.26. Australia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.27. Australia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.28. Indonesia Regenerative Medicine For Cartilage Market

      13.29. Indonesia Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.30. Indonesia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.31. Indonesia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.32. South Korea Regenerative Medicine For Cartilage Market

      13.33. South Korea Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.34. South Korea Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.35. South Korea Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.36. South Korea Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. Western Europe Regenerative Medicine For Cartilage Market

      14.1. Western Europe Regenerative Medicine For Cartilage Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulatory Bodies

      14.1.6. Regulations

      14.1.7. Taxes Levied

      14.1.8. Corporate Tax Structure

      14.1.9. Associations

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.3. Western Europe Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.4. Western Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.5. Western Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. Western Europe Regenerative Medicine For Cartilage Market: Country Analysis

      14.7. UK Regenerative Medicine For Cartilage Market

      14.8. UK Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.9. UK Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.10. UK Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.11. UK Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.12. Germany Regenerative Medicine For Cartilage Market

      14.13. Germany Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.14. Germany Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.15. Germany Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.16. Germany Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.17. France Regenerative Medicine For Cartilage Market

      14.18. France Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.19. France Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.20. France Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.21. France Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. Eastern Europe Regenerative Medicine For Cartilage Market

      15.1. Eastern Europe Regenerative Medicine For Cartilage Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Companies

      15.2. Eastern Europe Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.3. Eastern Europe Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.4. Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.5. Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. Eastern Europe Regenerative Medicine For Cartilage Market: Country Analysis

      15.7. Russia Regenerative Medicine For Cartilage Market

      15.8. Russia Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.9. Russia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.10. Russia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. North America Regenerative Medicine For Cartilage Market

      16.1. North America Regenerative Medicine For Cartilage Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Taxes Levied

      16.1.8. Corporate Tax Structure

      16.1.9. Associations

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.3. North America Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.4. North America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.5. North America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. North America Regenerative Medicine For Cartilage Market: Country Analysis

      16.7. USA Regenerative Medicine For Cartilage Market

      16.8. USA Regenerative Medicine For Cartilage Market Overview

      16.8.1. Region Information

      16.8.2. Market Information

      16.8.3. Background Information

      16.8.4. Government Initiatives

      16.8.5. Regulations

      16.8.6. Regulatory Bodies

      16.8.7. Taxes Levied

      16.8.8. Corporate Tax Structure

      16.8.9. Associations

      16.8.10. Investments

      16.8.11. Major Companies

      16.9. USA Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.10. USA Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.11. USA Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.12. USA Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. South America Regenerative Medicine For Cartilage Market

      17.1. South America Regenerative Medicine For Cartilage Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.3. South America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.4. South America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.5. South America Regenerative Medicine For Cartilage Market: Country Analysis

      17.6. Brazil Regenerative Medicine For Cartilage Market

      17.7. Brazil Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.8. Brazil Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.9. Brazil Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Middle East Regenerative Medicine For Cartilage Market

      18.1. Middle East Regenerative Medicine For Cartilage Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      18.3. Middle East Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      18.4. Middle East Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18.5. Middle East Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19. Africa Regenerative Medicine For Cartilage Market

      19.1. Africa Regenerative Medicine For Cartilage Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Regenerative Medicine For Cartilage Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      19.3. Africa Regenerative Medicine For Cartilage Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      19.4. Africa Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19.5. Africa Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      20. Regenerative Medicine For Cartilage Market Competitive Landscape

      20.1. Company Profiles

      20.2. Smith & Nephew plc

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Stryker Corporation

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Zimmer Biomet Holdings Inc.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. B. Braun Melsungen AG

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Arthrex Inc.

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The Regenerative Medicine For Cartilage Market

      21.1. Cesca Therapeutics Inc Acquired ThermoGenesis Corp

      21.2. Bioventus Inc. Acquired Misonix Inc.

      21.3. Bioventus Inc. Acquired CartiHeal

      21.4. Gaensel Energy Group Inc Acquired Swiss Stem Cells Biotech (SSCB)

      21.5. Gaensel Energy Group Inc Acquired a Stake in RE-YOU SUISSE

      21.6. Boehringer Ingelheim Acquired Global Stem cell Technology (GST)

      21.7. Gene Techno Science Co., Ltd. Acquired Shares Of Japan Regenerative Medicine Co., Ltd.

      21.8. Sartorius Acquired Biological Industries

      21.9. Smith & Nephew Plc Acquired Osiris Therapeutics, Inc.

      21.10. Black Beret Life Sciences LLC Acquired Okyanos Operating Company, Ltd.

      22. Regenerative Medicine For Cartilage Market Opportunities And Strategies

      22.1. Global Regenerative Medicine For Cartilage Market In 2026 – Countries Offering Most New Opportunities

      22.2. Global Regenerative Medicine For Cartilage Market In 2026 – Segments Offering Most New Opportunities

      22.3. Global Regenerative Medicine For Cartilage Market In 2026 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Regenerative Medicine For Cartilage Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Place

      23.2.3. Price

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright And Disclaimer

    List Of Tables

      Table 1: Global Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Modality, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Modality, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Regenerative Medicine For Cartilage Market, Segmentation By Site, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Regenerative Medicine For Cartilage Market, Segmentation By Site, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Regenerative Medicine For Cartilage Market, Segmentation By Types, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Global Regenerative Medicine For Cartilage Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 14: Global Regenerative Medicine For Cartilage Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 15: Global Regenerative Medicine For Cartilage Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 16: Global Regenerative Medicine For Cartilage Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 17: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 18: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 19: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 20:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 21: Asia Pacific Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 22: Asia-Pacific Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
    • Table 23: Asia-Pacific Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 24: Asia-Pacific Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 25: Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 26: Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 27: Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 28: Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 29: China GDP Per Capita, 2015-2020, $
    • Table 30: China, Population By Age Group, 2015-2025, Thousands
    • Table 31:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 32: China Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 33: China, Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
    • Table 34: China Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 35: China Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 36: China Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 37: China Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 38: China Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 39: China Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 40: India Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 41: India Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 42: India Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 43: India Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 44: India Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 45: India Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 46: Japan Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 47: Japan Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 48: Japan Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 49: Japan Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 50: Japan Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 51: Japan Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 52: Australia Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 53: Australia Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 54: Australia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 55: Australia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 56: Australia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 57: Australia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 58: Indonesia Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 59: Indonesia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 60: Indonesia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 61: Indonesia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 62: Indonesia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 63: South Korea Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 64: South Korea Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 65: South Korea Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 66: South Korea Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 67: South Korea Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 68: South Korea Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 69: Western Europe GDP Per Capita, 2015-2020, $
    • Table 70: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 71:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 72:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 73: Western Europe Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 74: Western Europe, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 75: Western Europe Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 76: Western Europe Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 77: Western Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 78: Western Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 79: Western Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 80: Western Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 81: UK Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 82: UK Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 83: UK Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 84: UK Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 85: UK Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 86: UK Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 87: Germany Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 88: Germany Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 89: Germany Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 90: Germany Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 91: Germany Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 92: Germany Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 93: France Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 94: France Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 95: France Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 96: France Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 97: France Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 98: France Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 99: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 100: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 101:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 102:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 103: Eastern Europe Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 104: Eastern Europe, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 105: Eastern Europe Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 106: Eastern Europe Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 107: Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 108: Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 109: Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 110: Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 111: Russia Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 112: Russia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 113: Russia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 114: Russia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 115: Russia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 116: North America GDP Per Capita, 2015-2020, $
    • Table 117: North America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 118:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 119:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 120: North America Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 121: North America, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 122: North America Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 123: North America Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 124: North America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 125: North America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 126: North America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 127: North America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 128: USA GDP Per Capita, 2015-2020, $
    • Table 129: USA, Population By Age Group, 2015-2025, Thousands
    • Table 130:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 131: USA Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 132: USA, Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
    • Table 133: USA Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 134: USA Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 135: USA Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 136: USA Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 137: USA Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 138: USA Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 139: South America GDP Per Capita, 2015-2020, $
    • Table 140: South America, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 141:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 142:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 143: South America Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 144: South America, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 145: South America Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 146: South America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 147: South America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 148: South America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 149: South America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 150: Brazil Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 151: Brazil Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 152: Brazil Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 153: Brazil Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 154: Brazil Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 155: Middle East GDP Per Capita, 2015-2020, $
    • Table 156: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 157:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 158:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 159: Middle East Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 160: Middle East Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 161: Middle East Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 162: Middle East Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 163: Middle East Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 164: Middle East Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 165: Middle East Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 166: Middle East Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 167: Africa GDP Per Capita, 2015-2020, $
    • Table 168: Africa, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 169:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 170:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 171: Africa Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
    • Table 172: Africa Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
    • Table 173: Africa Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Table 174: Africa Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 175: Africa Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 176: Africa Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 177: Africa Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 178: Africa Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 179: Global Regenerative Medicine For Cartilage Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 180: Smith & Nephew plc – Financial Overview, 2016 - 2020, $ Billion
    • Table 181: Stryker Corporation – Financial Overview, 2016 - 2020, $ Billion
    • Table 182: Zimmer Biomet Holdings – Financial Overview, 2016 - 2020, $ Billion
    • Table 183: B. Braun Melsungen AG – Financial Overview, 2016 - 2020, $ Billion
    • Table 184: Global Regenerative Medicine For Cartilage Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 185: Global Regenerative Medicine For Cartilage Market Size Gain ($ Million), Segmentation By Treatment Modality, 2021 – 2026
    • Table 186: Global Regenerative Medicine For Cartilage Market Size Gain ($ Million), Segmentation By Treatment Type, 2021 – 2026
    • Table 187: Global Regenerative Medicine For Cartilage Market Size Gain ($ Million), Segmentation By Site, 2021 – 2026
    • Table 188: Global Regenerative Medicine For Cartilage Market Size Gain ($ Million), Segmentation By Application, 2021 – 2026
    • Table 189: Global Regenerative Medicine For Cartilage Market Size Gain ($ Million), Segmentation By End-Use, 2021 – 2026
    • Table 190: Regenerative Medicine For Cartilage - Market Data Sources

    List Of Figures

      Figure 1: Global Regenerative Medicine For Cartilage Market Segmentation By Treatment Modality
    • Figure 2: Global Regenerative Medicine For Cartilage Market Segmentation By Treatment Type
    • Figure 3: Global Regenerative Medicine For Cartilage Market Segmentation By Site
    • Figure 4: Global Regenerative Medicine For Cartilage Market Segmentation By Application
    • Figure 5: Global Regenerative Medicine For Cartilage Market Segmentation By End-Use
    • Figure 6: Global Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 7: Global Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 8: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Modality, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 9: Global Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 10: Global Regenerative Medicine For Cartilage Market, Segmentation By Site, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 11: Global Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 12: Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 13: Global Regenerative Medicine For Cartilage Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 14: Global Regenerative Medicine For Cartilage Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 15: Asia-Pacific Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 16: Asia-Pacific Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 17: Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 18: Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 19: China Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 20: China Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 21: China Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 22: China Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 23: India Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 24: India Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 25: India Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 26: India Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 27: Japan Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 28: Japan Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 29: Japan Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 30: Japan Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 31: Australia Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 32: Australia Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 33: Australia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 34: Australia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 35: Indonesia Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 36: Indonesia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 37: Indonesia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 38: South Korea Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 39: South Korea Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 40: South Korea Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 41: South Korea Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 42: Western Europe Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 43: Western Europe Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 44: Western Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 45: Western Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 46: UK Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 47: UK Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 48: UK Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 49: UK Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 50: Germany Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 51: Germany Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 52: Germany Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 53: Germany Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 54: France Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 55: France Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 56: France Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 57: France Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 58: Eastern Europe Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 59: Eastern Europe Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 60: Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 61: Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 62: Russia Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 63: Russia Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 64: Russia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 65: North America Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 66: North America Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 67: North America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 68: North America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 69: USA Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 70: USA Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 71: USA Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 72: USA Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 73: South America Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 74: South America Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 75: South America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 76: Brazil Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 77: Brazil Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 78: Brazil Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 79: Middle East Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 80: Middle East Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 81: Middle East Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 82: Middle East Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 83: Africa Regenerative Medicine For Cartilage Market, Historic, 2016 – 2021, $ Million
    • Figure 84: Africa Regenerative Medicine For Cartilage Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 85: Africa Regenerative Medicine For Cartilage Market, Segmentation By Treatment Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 86: Africa Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 87: Global Regenerative Medicine For Cartilage Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 88: Smith & Nephew plc – Financial Overview, 2016 – 2020, $ Billion
    • Figure 89: Stryker Corporation – Financial Overview, 2016 – 2020, $ Billion
    • Figure 90: Zimmer Biomet – Financial Overview, 2016 - 2020, $ Billion
    • Figure 91: B. Braun Melsungen AG – Financial Overview, 2016 – 2020, $ Billion
    Global Contract Research And Manufacturing Services (CRAMS) Market Size, Forecasts, And Opportunities – Includes CRAMS Market Overview
    Global Pulmonary Arterial Hypertension Market Overview And Prospects – Includes Pulmonary Arterial Hypertension Market Share
    Global Botanical Supplements Market Outlook, Opportunities And Strategies – Includes Botanical Supplements Industry
    Global Pharmacovigilance Market Size, Forecasts, And Opportunities – Includes Pharmacovigilance Market Share
    Global Herbal Supplements Market Outlook, Opportunities And Strategies – Includes Herbal Supplements Market Size
    Global Hyperphosphatemia Treatment Market Outlook, Opportunities And Strategies – Including Hyperphosphatemia Treatment Algorithm
    Global Multivitamin Capsules And Tablets Market Size, Forecasts, And Opportunities – Includes Vitamin Industry Trends
    Global Naloxone Spray Market Overview And Prospects – Including pharmacies
    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Vaccines Market 2021 - By Type (Anti-Infective Vaccines, Anti-Cancer Vaccines, Others), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Other Route of Administration), By Valance (Monovalent, Multivalent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Ophthalmology Drugs Market - By Type (Antiglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Prescription Type (OTC Drugs, Prescription Drugs), By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Drug Variation (Branded Drugs, Generic Drugs), And, By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Microbiome Global Market Report 2022 – By Type (Fecal Microbiota Transplantation (FMT), Microbiome drugs), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis), By Technology (Genomics, Proteomics, Metabolomics) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Gene Therapy Global Market Report 2022 – By Gene Type (Antigen, Cytokine, Suicide Gene), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases), By End Users (Hospitals, Homecare, Specialty Clinics) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Cell Therapy Global Market Report 2022 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing) – Market Size, Trends, And Global Forecast 2022-2026
    View Report